Addex Therapeutics Stock Price History
| ADXN Stock | USD 9.44 0.04 0.43% |
Below is the normalized historical share price chart for Addex Therapeutics extending back to January 29, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Addex Therapeutics stands at 9.44, as last reported on the 4th of October, with the highest price reaching 9.83 and the lowest price hitting 9.17 during the day.
If you're considering investing in Addex Stock, it is important to understand the factors that can impact its price. Addex Therapeutics appears to be slightly risky, given 3 months investment horizon. Addex Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0544, which signifies that the company had a 0.0544% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Addex Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Addex Therapeutics' mean deviation of 3.67, and Risk Adjusted Performance of 0.0631 to double-check if our risk estimates are consistent with your expectations.
At this time, Addex Therapeutics' Common Stock Total Equity is very stable compared to the past year. As of the 4th of October 2024, Common Stock Shares Outstanding is likely to grow to about 78 M, while Total Stockholder Equity is likely to drop about 1.1 M. . At this time, Addex Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 4th of October 2024, Price To Book Ratio is likely to grow to 346.47, while Price To Sales Ratio is likely to drop 222.62. Addex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of January 2020 | 200 Day MA 10.0842 | 50 Day MA 9.1039 | Beta 1.978 |
Addex |
Sharpe Ratio = 0.0544
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ADXN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.41 actual daily | 65 65% of assets are less volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Addex Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Addex Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.6722 | Enterprise Value Ebitda (0.76) | Price Sales 11.6395 | Shares Float 34.2 M | Wall Street Target Price 30.01 |
Addex Therapeutics Stock Price History Chart
There are several ways to analyze Addex Stock price data. The simplest method is using a basic Addex candlestick price chart, which shows Addex Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | August 27, 2024 | 11.58 |
| Lowest Price | August 5, 2024 | 7.2 |
Addex Therapeutics October 4, 2024 Stock Price Synopsis
Various analyses of Addex Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Addex Stock. It can be used to describe the percentage change in the price of Addex Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Addex Stock.| Addex Therapeutics Price Action Indicator | (0.04) | |
| Addex Therapeutics Price Rate Of Daily Change | 1.00 | |
| Addex Therapeutics Accumulation Distribution | 1,047 | |
| Addex Therapeutics Price Daily Balance Of Power | 0.06 |
Addex Therapeutics October 4, 2024 Stock Price Analysis
Addex Stock Price History Data
The price series of Addex Therapeutics for the period between Sat, Jul 6, 2024 and Fri, Oct 4, 2024 has a statistical range of 4.38 with a coefficient of variation of 13.85. The prices are distributed with arithmetic mean of 8.88. The median price for the last 90 days is 8.3. The company had 1:20 stock split on 23rd of October 2023.| Open | High | Low | Close | Volume | ||
| 10/04/2024 | 9.17 | 9.83 | 9.17 | 9.44 | 15,592 | |
| 10/03/2024 | 9.12 | 10.00 | 8.83 | 9.40 | 65,727 | |
| 10/02/2024 | 9.23 | 9.32 | 8.90 | 9.28 | 14,867 | |
| 10/01/2024 | 9.75 | 10.00 | 9.23 | 9.23 | 49,530 | |
| 09/30/2024 | 9.98 | 10.00 | 9.50 | 9.77 | 13,822 | |
| 09/27/2024 | 9.63 | 10.15 | 8.92 | 9.05 | 23,530 | |
| 09/26/2024 | 9.68 | 10.16 | 9.35 | 9.63 | 12,201 | |
| 09/25/2024 | 10.50 | 10.50 | 9.32 | 9.95 | 65,194 | |
| 09/24/2024 | 10.35 | 10.66 | 10.21 | 10.21 | 33,745 | |
| 09/23/2024 | 9.89 | 10.75 | 9.88 | 10.60 | 20,418 | |
| 09/20/2024 | 9.70 | 10.40 | 9.65 | 9.84 | 39,450 | |
| 09/19/2024 | 9.77 | 10.20 | 9.21 | 9.67 | 43,982 | |
| 09/18/2024 | 9.93 | 9.98 | 9.25 | 9.59 | 27,480 | |
| 09/17/2024 | 9.95 | 10.40 | 9.70 | 10.13 | 26,562 | |
| 09/16/2024 | 9.94 | 10.40 | 9.50 | 10.10 | 61,909 | |
| 09/13/2024 | 10.07 | 10.47 | 9.51 | 9.64 | 46,703 | |
| 09/12/2024 | 10.46 | 10.86 | 10.15 | 10.21 | 28,875 | |
| 09/11/2024 | 10.33 | 10.65 | 9.40 | 10.30 | 46,600 | |
| 09/10/2024 | 10.88 | 11.00 | 10.50 | 10.54 | 8,192 | |
| 09/09/2024 | 10.98 | 11.18 | 10.75 | 10.98 | 11,169 | |
| 09/06/2024 | 11.31 | 11.47 | 10.62 | 11.18 | 32,189 | |
| 09/05/2024 | 10.55 | 11.34 | 10.55 | 11.31 | 49,467 | |
| 09/04/2024 | 10.51 | 10.82 | 10.14 | 10.70 | 11,352 | |
| 09/03/2024 | 10.58 | 11.77 | 10.12 | 11.48 | 71,090 | |
| 08/30/2024 | 10.16 | 11.49 | 10.16 | 10.86 | 76,351 | |
| 08/29/2024 | 9.90 | 10.97 | 9.55 | 10.23 | 142,775 | |
| 08/28/2024 | 11.25 | 11.29 | 9.61 | 10.61 | 311,702 | |
| 08/27/2024 | 12.00 | 13.27 | 10.05 | 11.58 | 16,734,007 | |
| 08/26/2024 | 7.49 | 7.83 | 7.49 | 7.66 | 2,217 | |
| 08/23/2024 | 7.90 | 7.90 | 7.60 | 7.65 | 3,890 | |
| 08/22/2024 | 7.69 | 7.95 | 7.62 | 7.90 | 3,651 | |
| 08/21/2024 | 7.90 | 8.14 | 7.24 | 7.60 | 15,252 | |
| 08/20/2024 | 7.73 | 7.73 | 7.73 | 7.73 | 498.00 | |
| 08/19/2024 | 7.27 | 7.75 | 7.27 | 7.73 | 498.00 | |
| 08/16/2024 | 7.83 | 8.15 | 7.35 | 7.50 | 22,911 | |
| 08/15/2024 | 7.85 | 7.99 | 7.61 | 7.62 | 3,469 | |
| 08/14/2024 | 7.94 | 8.16 | 7.63 | 7.67 | 15,511 | |
| 08/13/2024 | 7.75 | 8.11 | 7.75 | 7.77 | 5,053 | |
| 08/12/2024 | 7.95 | 8.05 | 7.75 | 8.05 | 8,467 | |
| 08/09/2024 | 7.76 | 8.07 | 7.71 | 7.90 | 4,460 | |
| 08/08/2024 | 7.80 | 8.49 | 7.70 | 7.70 | 7,137 | |
| 08/07/2024 | 8.29 | 8.29 | 7.51 | 7.51 | 458.00 | |
| 08/06/2024 | 7.99 | 7.99 | 7.65 | 7.87 | 4,319 | |
| 08/05/2024 | 7.43 | 7.84 | 7.20 | 7.20 | 5,907 | |
| 08/02/2024 | 7.85 | 7.90 | 7.84 | 7.90 | 509.00 | |
| 08/01/2024 | 8.01 | 8.02 | 7.80 | 8.00 | 6,398 | |
| 07/31/2024 | 8.35 | 8.69 | 8.14 | 8.16 | 6,073 | |
| 07/30/2024 | 8.04 | 8.04 | 7.90 | 8.00 | 1,564 | |
| 07/29/2024 | 8.33 | 8.35 | 8.01 | 8.01 | 710.00 | |
| 07/26/2024 | 8.00 | 8.00 | 8.00 | 8.00 | 1.00 | |
| 07/25/2024 | 8.00 | 8.00 | 8.00 | 8.00 | 45.00 | |
| 07/24/2024 | 8.17 | 8.17 | 8.00 | 8.00 | 400.00 | |
| 07/23/2024 | 8.10 | 8.29 | 7.94 | 8.12 | 2,043 | |
| 07/22/2024 | 8.18 | 8.18 | 7.97 | 8.06 | 8,542 | |
| 07/19/2024 | 8.02 | 8.18 | 8.02 | 8.10 | 700.00 | |
| 07/18/2024 | 8.30 | 8.30 | 8.01 | 8.01 | 3,661 | |
| 07/17/2024 | 8.24 | 8.27 | 8.22 | 8.24 | 1,022 | |
| 07/16/2024 | 8.10 | 8.26 | 8.01 | 8.26 | 1,406 | |
| 07/15/2024 | 8.02 | 8.40 | 8.02 | 8.32 | 1,691 | |
| 07/12/2024 | 8.32 | 8.36 | 8.20 | 8.30 | 1,025 | |
| 07/11/2024 | 8.40 | 8.40 | 8.40 | 8.40 | 201.00 |
About Addex Therapeutics Stock history
Addex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Addex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Addex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Addex Therapeutics stock prices may prove useful in developing a viable investing in Addex Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 74.3 M | 78 M | |
| Net Loss | -18.7 M | -17.8 M |
Addex Therapeutics Stock Technical Analysis
Addex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Addex Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Addex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Addex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Addex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0631 | |||
| Jensen Alpha | 0.4275 | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | 0.1045 | |||
| Treynor Ratio | 0.7575 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Information and Resources on Investing in Addex Stock
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.85) | Revenue Per Share 1.2 | Quarterly Revenue Growth (0.82) | Return On Assets (0.62) | Return On Equity (1.26) |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.